Binnopharm Group has become a leader in digital promotion among Russian pharmaceutical companies

According to the Promo study “Monitoring the promotional activity of pharmaceutical companies”, Binnopharm Group took second place among all pharmaceutical companies in the number of contacts with pharmacists, demonstrating a 48% increase compared to the same period last year. The company continues to develop multichannel promotion: the volume of communications through electronic mailings is growing, for which Binnopharm Group occupies a leading position among the TOP5 companies.

The company demonstrates a balanced distribution of promotional activity in the OTC and Rx drug segments: 46% of contacts are with pharmacists and 54% with doctors. In the Rx segment, Binnopharm Group places a more pronounced emphasis on the pharmacy channel than its competitors (28% of the total promotion volume).

In addition, Binnopharm Group is among the TOP10 pharmaceutical companies both in terms of the total number of contacts with doctors and pharmacists and in terms of the positive dynamics of these interactions.

The company's over-the-counter portfolio ranks third in terms of the number of promotions and programs in pharmacies. The anti-cold, venotonic and antispasmodic brands are promoted especially actively. In the prescription segment, Binnopharm Group confidently holds the second position. The key brands of the Rx portfolio are NSAIDs and an antiulcer drug.

"Today, the effectiveness of promotion is not just the number of contacts, but their quality, timeliness and personalized approach. We consciously rely on digital channels and multichannel strategies to be closer to the medical community and respond to their requests faster. Our growth is the result of systematic work and the trust of professionals in our brands," said Ekaterina Slavgorodskaya, Director of Sales and Promotion at Binnopharm Group .